-transparent.png){kind=logo}
Fendosal (200 mg) was given orally to each of two separate groups of twelve healthy male volunteers on separate occasions to assess the influence of food or antacid on the bioavailability of fendosal. Blood samples (20 ml) were drawn during 12 hours post-dosing and fendosal plasma concentrations were quantitated by a validated fluorescence technique. Food was shown to have no significant effect (p greater than 0.05) on fendosal bioavailability. However, the bioavailability of fendosal in the presence of an antacid was reduced by 80 per cent. In vitro studies suggested that a complexation between unionized fendosal and the metal ions contained in the antacid may be responsible for the decrease in the rate and extent of absorption observed in vivo.
R J Wills, and
R B Velagapudi, and
S K Puri, and
G J Yakatan
August 1990,
Journal of clinical pharmacology,
R J Wills, and
R B Velagapudi, and
S K Puri, and
G J Yakatan
May 1990,
The Journal of pharmacy and pharmacology,
R J Wills, and
R B Velagapudi, and
S K Puri, and
G J Yakatan
March 1980,
International journal of clinical pharmacology, therapy, and toxicology,
R J Wills, and
R B Velagapudi, and
S K Puri, and
G J Yakatan
February 2009,
Cancer chemotherapy and pharmacology,
R J Wills, and
R B Velagapudi, and
S K Puri, and
G J Yakatan
June 1992,
Antimicrobial agents and chemotherapy,
R J Wills, and
R B Velagapudi, and
S K Puri, and
G J Yakatan
January 1984,
Journal of clinical pharmacology,
R J Wills, and
R B Velagapudi, and
S K Puri, and
G J Yakatan
January 1983,
Biopharmaceutics & drug disposition,
R J Wills, and
R B Velagapudi, and
S K Puri, and
G J Yakatan
August 1979,
American journal of hospital pharmacy,
R J Wills, and
R B Velagapudi, and
S K Puri, and
G J Yakatan
July 1972,
The Journal of clinical pharmacology and new drugs,
R J Wills, and
R B Velagapudi, and
S K Puri, and
G J Yakatan
October 1975,
Journal of pharmaceutical sciences,
